F028 Advanced Laser Techniques
DESCRIPTION
Open admission to eligible categories, no tuition or ticket
This session is designed for experienced laser surgeons as well as medical dermatologists seeking new therapeutic options. Expert faculty will provide advanced treatment algorithms and clinically relevant laser and light procedure techniques on topics including: laser safety, vascular lesions, pigmented lesions, skin tightening, laser resurfacing including scar revision, and considerations in skin of color. The topics will focus on cutting-edge approaches for traditional and novel indications with an emphasis on practical approaches, and will include guidance on how to diagnose, manage, and avoid complications in order to improve clinical outcomes and patient satisfaction.
LEARNING OBJECTIVES
Recognize appropriate clinical endpoints for assessing treatment parameters with laser and light procedures.
Assess safe practices of laser and light procedures and describe potential complications and how to manage them.
Discuss new and emerging technologies and controversies in the field of laser and light therapy.
SCHEDULE
2:00 PM
Introduction
Arisa Ortiz, MD, FAAD
2:05 PM
Advanced Laser Therapies for Vascular Lesions: Port-Wine Stains to Rosacea
Aria Vazirnia, MD, FAAD
2:17 PM
Picosecond Lasers: Expanding Indications for Tattoo Removal and Skin Rejuvenation
E. Victor Ross Jr., MD, FAAD
2:29 PM
Next-Generation Fractional Lasers: Innovations in Skin Resurfacing & Microcoring
Omar Ibrahimi, MD, PhD, FAAD
2:41 PM
Combining Modalities with Fully Ablative Resurfacing for Superior Aesthetic Outcomes
Joel Lee Cohen, MD, FAAD
2:53 PM
Question & Answer Session
3:03 PM
Multi-Layered Approaches: RF and Ultrasound for Optimal Skin Tightening
Swati Kannan, MD
3:15 PM
Scar Revision Revolution: Integrating Regenerative Therapies with Laser Technologies for Optimal Outcomes
Jill S. Waibel, MD, FAAD
3:27 PM
Innovative and Inclusive Approaches: Advancing Safe & Effective Treatments for Skin of Color
Jeanine B. Downie, MD, FAAD
3:39 PM
A Comprehensive Treatment Strategy to Improve and Prevent the Signs of Aging
Arisa Ortiz, MD, FAAD
3:51 PM
Question & Answer Session
SPEAKERS
Joel Lee Cohen, MD, FAAD
Jeanine B. Downie, MD, FAAD
Omar Ibrahimi, MD, PhD, FAAD
Swati Kannan, MD
Arisa Ortiz, MD, FAAD
E. Victor Ross Jr., MD, FAAD
Aria Vazirnia, MD, FAAD
Jill S. Waibel, MD, FAAD
SPEAKER DISCLOSURES
Joel Lee Cohen, MD, FAAD
Acclaro Medical – Advisory Board(Grants/Research Funding); Accure Medical, LLC – Investigator(Stock Options); Allergan, Inc. – Consultant(Honoraria); BTL Industries – Investigator(Grants/Research Funding); Cutera, Inc. – Investigator(Grants/Research Funding); Cynosure-Lutronic – Investigator(Grants/Research Funding); Ferndale Laboratories, Inc. – Investigator(Grants/Research Funding); Galderma USA – Consultant(Honoraria), Investigator(Grants/Research Funding); InMode – Investigator(Grants/Research Funding); Merz Pharmaceuticals, LLC – Consultant(Honoraria); Revance Therapeutics, Inc. – Investigator(Grants/Research Funding); Sciton Inc. – Consultant(Honoraria); Swift arc ventures – Investigator(Grants/Research Funding);
Jeanine B. Downie, MD, FAAD
No financial relationships exist with ineligible companies.
Omar Ibrahimi, MD, PhD, FAAD
AbbVie – Stockholder(Stock); Accure, Inc – Advisory Board(No Compensation Received); Acure Acne – Stockholder(Stock); Allergan, Inc – Advisory Board(Honoraria); AVAVA, LLC – Investigator(Grants/Research Funding); Beam Therapeutics – Stockholder(Stock); CRISPR Therapeutics – Stockholder(Stock); Cutera, Inc. – Speaker(Honoraria); Cytrellis Biosystems, Inc – Advisory Board(Honoraria); Editas Medicine – Stockholder(Stock); Gingko Bioworks Holding Inc – Stockholder(Stock); Intellia Therapeutics – Stockholder(Stock); Lutronic – Advisory Board(Honoraria); Moderna Therapeutics – Stockholder(Stock); Pfizer Inc. – Stockholder(Stock); Procter & Gamble Company – Stockholder(Stock); Revance Therapeutics, Inc. – Stockholder(Stock); Unilever – Stockholder(Stock); Vertex Pharmaceuticals, Inc. – Stockholder(Stock);
Swati Kannan, MD
No financial relationships exist with ineligible companies.
Arisa Ortiz, MD, FAAD
Aerolase – Advisory Board(Honoraria), Other(Equipment); Allergan, Inc – Advisory Board(Honoraria), Speaker(Honoraria); Bausch Health – Advisory Board(Honoraria); Cutera, Inc. – Consultant(Honoraria); Galderma USA – Advisory Board(Honoraria); Procter & Gamble Company – Consultant(Honoraria); Revance Therapeutics, Inc. – Investigator(Grants/Research Funding); Sciton Inc. – Advisory Board(Honoraria), Speaker(Honoraria); SmartGraft – Consultant(Equipment); Sofwave – Speaker(Honoraria);
E. Victor Ross Jr., MD, FAAD
Acclaro Medical – Investigator(Grants/Research Funding); Benev – Consultant(Honoraria); Cutera, Inc. – Investigator(Equipment); laser optek – Other(Honoraria); laseroptek – Other(Honoraria); Lumenis – Investigator(Equipment), Investigator(Honoraria); Lutronic – Consultant(Honoraria); Venus Concept – Investigator(Grants/Research Funding);
Aria Vazirnia, MD, FAAD
Bausch Health – Consultant (1099 relationship)(Honoraria);
Jill S. Waibel, MD, FAAD
Allergan – Consultant (1099 relationship)(Honoraria); Amgen – Investigator(Grants/Research Funding); argenx – Investigator(Grants/Research Funding); BellaMia Technologies Inc. – Advisory Board(No Compensation Received); Bristol-Myers Squibb – Investigator(Grants/Research Funding); Candela Corporation – Consultant (1099 relationship)(Honoraria); Cytrellis Biosystems, Inc – Advisory Board(No Compensation Received), Investigator(Grants/Research Funding); Eli Lilly – Investigator(Grants/Research Funding), Speaker(No Compensation Received); Galderma – Consultant (1099 relationship)(No Compensation Received), Investigator(Grants/Research Funding); Johnson & Johnson Innovative Medicine – Investigator(Grants/Research Funding); Lumenis – Advisory Board(Honoraria), Consultant (1099 relationship)(No Compensation Received), Speaker(Honoraria); Neuronetics NeuroStar – Investigator(Grants/Research Funding); Pfizer Inc. – Investigator(Grants/Research Funding); Procter & Gamble Company – Consultant (1099 relationship)(Honoraria); Regenx – Advisory Board(No Compensation Received), Investigator(Grants/Research Funding); Sanofi – Investigator(Grants/Research Funding); Shanghai Fudan-Zhangjiang Bio Pharmaceutical Co., Ltd. – Investigator(Grants/Research Funding); SkinCeuticals LLC – Advisory Board(Honoraria), Consultant (1099 relationship)(Honoraria), Investigator(Grants/Research Funding); VA Merit Grant – Other(No Compensation Received);